The Wilderness Medical Society practice guidelines by Luks et al 2019 on the prevention and treatment of acute altitude illness provide updated recommendations for both pharmacologic and nonpharmacologic management of Acute Mountain Sickness (AMS), High Altitude Cerebral Edema (HACE), and High Altitude Pulmonary Edema (HAPE).
The guidelines include the latest insights into the appropriate dosing of acetazolamide, the role of ibuprofen, and the utility of various forms of pre-acclimatization including intermittent hypoxic exposures and hypoxic tents.
Here are a few highlights and be sure to check out the full update at doi.org/10.1016/j.wem.2019.04.006.
#AltitudeSickness #WildernessMedicalSociety #WildernessMedicine #Guidelines,
